Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIn week 1 of tirzepatide, most people inject 2.5mg and notice very little in the way of weight loss — that is completely normal and expected. The first pen's job is to let your body adjust to the medicine, not to produce dramatic results. Side effects, if they appear at all, tend to peak in the first few days after your initial injection and then ease. These are prescription-only medicines assessed and approved by a GPhC-registered prescriber before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people do their first tirzepatide injection at home, following the instructions in the Patient Information Leaflet. The injection itself takes only seconds. For the first 24 to 48 hours, many people report nothing at all, no nausea, no changes to appetite, no obvious effect. That is not a sign the medicine isn't working. Tirzepatide builds steadily in your system rather than acting like a painkiller taken for immediate relief.
If side effects do arrive, they tend to show up between hours 12 and 36 after the injection. Nausea is the most common, followed by indigestion and, for some people, softer stools or mild stomach discomfort. These effects tend to be worst on the first or second day post-injection and then ease. Eating smaller meals, avoiding rich or fatty food, and staying well hydrated all help. The practical side of managing tirzepatide's first week is worth reading before you inject if you want to feel prepared.
One thing our prescribers hear regularly: patients worry the nausea means something has gone wrong. It usually means the opposite, the medicine is reaching the gut-hormone receptors it is designed to act on. Slowing gastric emptying is part of how tirzepatide works, and nausea is the body's initial response to that unfamiliar change.
By the middle of the first week, the acute effects often settle. Some people begin to notice a shift in appetite, meals feel satisfying sooner, or the pull toward snacking is quieter than usual. This early appetite change is real and tied to tirzepatide's dual action on GIP and GLP-1 receptors, both involved in regulating fullness signals. It is the only licensed dual-agonist weight-loss medicine in the UK on those two pathways. The NHS medicines page for tirzepatide describes this mechanism clearly if you want the detail.
Others notice nothing at 2.5mg, and that is equally normal. The starting dose is deliberately low, chosen for tolerability, not effect. It is the floor, not the ceiling. Your prescriber will increase the dose at roughly four-week intervals, and most people find the appetite and weight changes become clearer from 5mg or 7.5mg onwards.
On the scales in week 1: do not expect a meaningful number. Any early movement tends to reflect fluid shifts rather than fat loss, and focusing on week-1 numbers sets an unfair benchmark. The fuller picture of how long tirzepatide takes to work puts the first week in proper context alongside results at 12, 24 and 72 weeks.
Before week 2 arrives, it is worth noting a few things: how the injection went, whether any side effects appeared and how long they lasted, and whether you noticed any early change in hunger. This is not busywork. Your prescriber reviews this kind of information when considering whether your dose increase is appropriate and on schedule.
Contact your prescriber or a healthcare professional promptly if you experience severe, persistent abdominal pain, particularly if it radiates through to your back. The MHRA issued a Yellow Card reporting system for reporting unexpected side effects; your prescriber can advise whether something warrants investigation. Signs of a serious allergic reaction (swelling of the face, lips or throat, or difficulty breathing) require urgent medical attention.
For most people, week 1 ends quietly. A log entry, a couple of adjusted meals, and the quiet awareness that something is starting. Week 2 is when the process begins to feel more established. If you are thinking about four-week results, that page covers what the evidence shows at the end of the first full pen.
Understanding how tirzepatide's results build over the longer arc helps set realistic expectations, how much weight loss to expect on tirzepatide covers the SURMOUNT trial data in full, with the context that matters. And if you are still weighing up whether to start, the free consultation with our prescribers is the right first step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.